{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-041092","form_type":"8-K","ticker":"CALC","cik":"0001534133","company_name":"CalciMedica, Inc.","filed_at":"2023-02-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.469381+00:00","generated_at":"2026-06-19T09:20:19.463692+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Graybug Vision enters $2M bridge loan with CalciMedica and amends merger terms","bullets":["Graybug agrees to lend CalciMedica up to $2M at 7.5% annual interest; initial $500K advanced.","Amendment ensures outstanding loan principal and interest included in Graybug's net cash for merger closing.","CalciMedica must use proceeds for payroll, rent, clinical trial, and regulatory costs; additional draws require Graybug approval.","Merger termination triggers mandatory prepayment or credit against termination fees; three-month maturity after anniversary."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-041092","json":"https://secwatch.observer/filing/0001193125-23-041092.json","markdown":"https://secwatch.observer/filing/0001193125-23-041092.md","text":"https://secwatch.observer/filing/0001193125-23-041092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523041092/0001193125-23-041092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523041092/d461698d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T09:20:19.463692+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e80c12700914931bed3f47523d9e879f3da6e24c","claim":"CalciMedica, Inc. entered into Note Purchase Agreement with Graybug Vision, Inc. valued at $2.0 million (effective 2023-02-10).","evidence_excerpt":"On February 10, 2023, Graybug Vision, Inc. (“Graybug”) and CalciMedica, Inc. (“CalciMedica”) entered into a note purchase agreement (the “Note Purchase Agreement”) providing for Graybug to make short-term loans (the “Loan” or “Loans”) to CalciMedica up to an aggregate principal amount of $2.0 million","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523041092/0001193125-23-041092-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"Graybug Vision, Inc."},{"label":"Value","value":"$2.0 million"},{"label":"Effective","value":"2023-02-10"}],"fact_type":"material_agreement"},{"claim_id":"f7597485839981ca565d533206702a4ce2386bec","claim":"CalciMedica, Inc. amended First Amendment with Graybug, CalciMedica and Camaro Merger Sub, Inc. (effective 2023-02-10).","evidence_excerpt":"In connection with the Note Purchase Agreement, on February 10, 2023, Graybug, CalciMedica and Camaro Merger Sub, Inc. (“Camaro Merger Sub”) entered into a First Amendment (the “Amendment”) to the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523041092/0001193125-23-041092-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Graybug, CalciMedica and Camaro Merger Sub, Inc."},{"label":"Effective","value":"2023-02-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}